As communities continue to be impacted by COVID-19, we are a reliable source for people in search of answers. We are working closely with our infectious disease experts, other health care entities, and federal, state, and local agencies to ensure our information is accurate and up to date.
Infants exposed to thirdhand smoke while hospitalized in the neonatal intensive care unit (NICU) show a difference in the composition of their gut microbiome, according to a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth).
There are an estimated one-million transgender adults living in the U.S. and an estimated 14% of transgender women are living with HIV. Researchers at UTHealth are studying if a combination intervention that combines HIV prevention services and hormonal therapy, supported by peer health navigation, will reduce HIV acquisition among this patient population.
Vincent Van Gogh's struggles with mental illness are often credited as the root of his artistic genius, but a UTHealth psychiatrist says that is just one thing that influenced the work of the world-renowned painter.
New artificial intelligence technology that uses a common CT angiography (CTA) as opposed to the more advanced imaging normally required to help identify patients who could benefit from endovascular stroke therapy (EST) is being developed at UTHealth.
Pregnant women who are hospitalized with COVID-19 and viral pneumonia are less likely than non-pregnant women to die from these infections, according to a new study by researchers with The University of Texas Health Science Center at Houston (UTHealth) and the University of Maryland School of Medicine (UMSOM).
A possible link between delirium and mortality in hospitalized older adults with acute heart failure exacerbation has been found by researchers at The University of Texas Health Science Center at Houston (UTHealth).
A fetal intervention team led by Ramesha Papanna, MD, MPH, of The University of Texas Health Science Center at Houston (UTHealth) has received a $3.2 million award from the National Institutes of Health (NIH) for preclinical research on a new approach to repair spina bifida in utero.
Black and Hispanic patients develop more disability from multiple sclerosis (MS) and respond to treatments for the disease differently compared to white patients who also have the disease, according to recent findings presented by researchers at UTHealth.
A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).
A Phase II clinical trial to assess mesenchymal adult stem cells as a disease-modifying therapy for Parkinson's disease has been launched at The University of Texas Health Science Center at Houston (UTHealth).
